Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $113
Wells Fargo analyst Wesley Carmichael maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $110 to $113.
Last updated: 2026-11-14 16:05:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
MetLife, Inc. (MET) operates in the LIFE INSURANCE sector and is listed on NYSE. The stock is currently priced at $102.66, with a market capitalization of $64.02B and a P/E ratio of 18.60. Over the past 52 weeks, its price has ranged from $67.33 to $106.72. This page covers its latest market performance, valuation, price trends and company information.
$64.02B | |
$102.83 | |
$103.14 | |
$101.46 | |
$101.87 | |
1.61M | |
3.13M | |
18.60 | |
$106.72 | |
$67.33 | |
2.63% | |
-- |
MetLife, Inc. (MET) last closed at $102.66 as of 2026-11-14 00:31:00, up 0.77% ($0.78) from the previous close of $101.87.
During the latest regular trading session, MET traded between $101.46 and $103.14, with a volume of 1.61M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, MetLife, Inc. (MET) moved from $99.75 to $102.66, representing a gain of 2.91% ($2.91).
The stock traded between $97.78 and $106.72 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 3.05 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 89.7%
MET is currently trading at $102.66, placing it 89.7% of the way from its 52-week low of $67.33 to its 52-week high of $106.72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
| Industry | LIFE INSURANCE |
| Employees | 46,000 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for MetLife, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Nov 3, 2026 |
| Payment Date | Dec 8, 2026 |
| Dividend Per Share | $0.5925 |
Latest news related to MetLife, Inc. and MET stock.
Wells Fargo analyst Wesley Carmichael maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $110 to $113.
Mizuho analyst Yaron Kinar maintains MetLife (NYSE:MET) with a Outperform and raises the price target from $112 to $117.
Eligible investors can buy real shares of MetLife, Inc. (MET) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MET, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MET shares and USD.
MET Shares to USD
1.00 MET shares = 102.655 USD
Calculations are estimates based on the latest available price and are for reference only.